Literature DB >> 19911261

Functional overexpression and purification of a codon optimized synthetic glucarpidase (carboxypeptidase G2) in Escherichia coli.

Sayed K Goda1, Fatma A Baoumi Rashidi, Ameena A Fakharo, Aisha Al-Obaidli.   

Abstract

Glucarpidase (former name: carboxypeptidase G2, or CPG2) is a bacterial enzyme that is widely used in detoxification of the cytotoxic drug, methotrexate, and in Antibody Directed Enzyme Prodrug Therapy for cancer treatment. The glucarpidase gene of Pseudomonas sp. strain RS-16 was previously cloned in E coli, but expresses at a level that is approximately 100-fold lower than in the native strain. In this study, a synthetic gene coding for glucarpidase was codon-optimised and synthesized for maximum expression in E. coli using the vector pET28a. Our work indicated that the enzyme was expressed to ~60% of the total host protein and that purification of the recombinant His-tagged protein could be achieved in a single step by Ni(2+) charged column chromatography. The synthetic recombinant glucarpidase expressed within this system was biologically active and zinc dependant. Our study showed that Mg(2+) as well as Mn(2+) ions inhibit the activity of the recombinant enzyme.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19911261     DOI: 10.1007/s10930-009-9211-2

Source DB:  PubMed          Journal:  Protein J        ISSN: 1572-3887            Impact factor:   2.371


  18 in total

Review 1.  Codon bias and heterologous protein expression.

Authors:  Claes Gustafsson; Sridhar Govindarajan; Jeremy Minshull
Journal:  Trends Biotechnol       Date:  2004-07       Impact factor: 19.536

2.  DnaK and DnaJ facilitated the folding process and reduced inclusion body formation of magnesium transporter CorA overexpressed in Escherichia coli.

Authors:  Yong Chen; Jinmei Song; Sen-fang Sui; Da-Neng Wang
Journal:  Protein Expr Purif       Date:  2003-12       Impact factor: 1.650

3.  Effect of osmotic stress and heat shock in recombinant protein overexpression and crystallization.

Authors:  Natalia Oganesyan; Irina Ankoudinova; Sung-Hou Kim; Rosalind Kim
Journal:  Protein Expr Purif       Date:  2006-10-10       Impact factor: 1.650

4.  Purification and properties of carboxypeptidase G 1 .

Authors:  J L McCullough; B A Chabner; J R Bertino
Journal:  J Biol Chem       Date:  1971-12-10       Impact factor: 5.157

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Purification and properties of carboxypeptidase G2 from Pseudomonas sp. strain RS-16. Use of a novel triazine dye affinity method.

Authors:  R F Sherwood; R G Melton; S M Alwan; P Hughes
Journal:  Eur J Biochem       Date:  1985-05-02

7.  Cloning characterization of iaaM, a virulence determinant of Pseudomonas savastanoi.

Authors:  L Comai; T Kosuge
Journal:  J Bacteriol       Date:  1982-01       Impact factor: 3.490

8.  Molecular cloning of the Pseudomonas carboxypeptidase G2 gene and its expression in Escherichia coli and Pseudomonas putida.

Authors:  N P Minton; T Atkinson; R F Sherwood
Journal:  J Bacteriol       Date:  1983-12       Impact factor: 3.490

9.  Expression of Pseudomonas fluorescens D-galactose dehydrogenase in E. coli.

Authors:  P Buckel; E Zehelein
Journal:  Gene       Date:  1981-12       Impact factor: 3.688

10.  A cytotoxic agent can be generated selectively at cancer sites.

Authors:  K D Bagshawe; C J Springer; F Searle; P Antoniw; S K Sharma; R G Melton; R F Sherwood
Journal:  Br J Cancer       Date:  1988-12       Impact factor: 7.640

View more
  3 in total

1.  Coupling of a Novel TIMP3 Peptide to Carboxypeptidase G2 for Pro-Drug Activation at the Tumour Site.

Authors:  Mohammed S Aldughaim; Fatimah Alsaffar; Michael D Barker
Journal:  Molecules       Date:  2021-01-25       Impact factor: 4.411

2.  Characterization of a Stable Form of Carboxypeptidase G2 (Glucarpidase), a Potential Biobetter Variant, From Acinetobacter sp. 263903-1.

Authors:  Issa Sadeghian; Shiva Hemmati
Journal:  Mol Biotechnol       Date:  2021-07-15       Impact factor: 2.695

3.  Isolation and molecular characterization of novel glucarpidases: Enzymes to improve the antibody directed enzyme pro-drug therapy for cancer treatment.

Authors:  Fatma B Rashidi; Alanod D AlQhatani; Sara S Bashraheel; Shabnam Shaabani; Matthew R Groves; Alexander Dömling; Sayed K Goda
Journal:  PLoS One       Date:  2018-04-26       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.